Parotid-gland-sparing 3D conformal radiotherapy in patients with bilateral radiotherapy of the head and neck region - Results in clinical practice

Oral Oncology

Volumn 45, Issue 2, 2009, Pages

  Hey, Jeremias ^a   Setz, Jürgen ^a   Gerlach, Reinhard ^b   Janich, Martin ^b   Sehlleier, Simone ^b   Schaller, Hans Günter ^a   Gernhardt, Christian R ^a   Kuhnt, Thomas ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Head and neck radiation; Hyposalivation; Parotid gland sparing; Saliva

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CALCULATION; CANCER RADIOTHERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FLOW RATE; HEAD AND NECK CARCINOMA; HISTOGRAM; HUMAN; HUMAN TISSUE; HYPOSALIVATION; IRRADIATION; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALIVATION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PAROTID GLAND; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; XEROSTOMIA;

EID: 58549106764     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.04.004     Document Type: Article

References (42)

1. Lin A., Kim H.M., Terrell J.E., Dawson L.A., Ship J.A., and Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 57 (2003) 61-70
2. Nishimura Y., Nakamatsu K., Shibata T., Kanamori S., Koike R., Okumura M., et al. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT. Jpn J Clin Oncol 35 (2005) 375-379
3. Huguenin P.U., Taussky D., Moe K., Meister A., Baumert B., Lutolf U.M., et al. Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume. Int J Radiat Oncol Biol Phys 45 (1999) 47-52
4. Gernhardt C.R., Koravu T., Gerlach R., and Schaller H.G. The influence of dentin adhesives on the demineralization of irradiated and non-irradiated human root dentin. Oper Dent. 29 (2004) 454-461
5. Valdez I.H., Atkinson J.C., Ship J.A., and Fox P.C. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int J Radiat Oncol Biol Phys 25 (1993) 41-47
6. Brown L.R., Dreizen S., Handler S., and Johnston D.A. Effect of radiation-induced xerostomia on human oral microflora. J Dent Res 54 (1975) 740-750
7. Andrews N., and Griffiths C. Dental complications of head and neck radiotherapy: Part 1. Aust Dent J 46 (2001) 88-94
8. Gernhardt C.R., Klapproth J., Gerlach R., and Schaller H.G. The influence of radiation on de- and remineralization of human dentin in vitro. Dtsch Zahnärztl Z 60 (2005) 166-171
9. Hahn P., Schaller H.G., Gernhardt C., and Hellwig E. Influence of two dentin bonding systems on the demineralization of the root surface. Oper Dent 24 (1999) 344-350
10. Cassolato S.F., and Turnbull R.S. Xerostomia: clinical aspects and treatment. Gerodontology 20 (2003) 64-77
11. Fox P.C. Acquired salivary dysfunction. Drugs and radiation. Ann NY Acad Sci 842 (1998) 132-137
12. Johnson J.T., Ferretti G.A., Nethery W.J., Valdez I.H., Fox P.C., Ng D., et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 329 (1993) 390-395
13. Blom M., Dawidson I., Fernberg J.O., Johnson G., and Angmar-Mansson B. Acupuncture treatment of patients with radiation-induced xerostomia. Eur J Cancer B Oral Oncol 32B (1996) 182-190
14. O'Connell A.C. Natural history and prevention of radiation injury. Adv Dent Res 14 (2000) 57-61
15. Chambers M.S., Rosenthal D.I., Weber R.S., Strnad V., Rudat V., and Monnier A. Radiation-induced xerostomia. Head Neck 29 (2007) 58-63
16. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18 (2000) 3339-3345
17. Wasserman T.H., Brizel D.M., Henke M., Monnier A., Eschwege F., Sauer R., et al. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys 63 (2005) 985-990
18. Rosenthal D.I., Chambers M.S., Weber R.S., and Eisbruch A. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing. Semin Oncol 31 (2004) 25-28
19. Amifostine reduces radiation therapy-induced dry mouth in head and neck cancer patients. Oncology (Williston Park) 2004;18:1314, 1316.
20. Gregoire V., Coche E., Cosnard G., Hamoir M., and Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 56 (2000) 135-150
21. Levendag P., Braaksma M., Coche E., van der E.H., Hamoir M., Muller K., et al. Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. Int J Radiat Oncol Biol Phys 58 (2004) 113-123
22. Astreinidou E., Dehnad H., Terhaard C.H., and Raaijmakers C.P. Level II lymph nodes and radiation-induced xerostomia. Int J Radiat Oncol Biol Phys 58 (2004) 124-131
23. Kuhnt T., Jirsak N., Muller A.C., Pelz T., Gernhardt C., and Schaller H.G. et al. Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer. Strahlenther Onkol 181 (2005) 520-528
24. Maes A., Weltens C., Flamen P., Lambin P., Bogaerts R., Liu X., et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 63 (2002) 203-211
25. Munter M.W., Karger C.P., Hoffner S.G., Hof H., Thilmann C., Rudat V., et al. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys 58 (2004) 175-184
26. Eisbruch A., Dawson L.A., Kim H.M., Bradford C.R., Terrell J.E., Chepeha D.B., et al. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg 53 (1999) 271-275
27. Sreebny L.M. Saliva in health and disease: an appraisal and update. Int Dent J 50 (2000) 140-161
28. Wittekind C., Meyer H.J., and Bootz F. UICC-TMN-Klassifikation maligner Tumoren. 6th ed. (2003), Springer-Verlag, Berlin/Heidelberg/New York
29. ICRU 50: Prescribing and Reporting Photon Beam Therapy. International commission on radiation units and measurements, vol. 1. Inc. ICRU News; 1993. p. 1-72.
30. ICRU 62: Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). international commission on radiation units and measurements, vol. 1. Inc. ICRU News; 1999. p. 1-8.
31. Lyman J.T., and Wolbarst A.B. Optimization of radiation therapy, IV: a dose-volume histogram reduction algorithm. Int J Radiat Oncol Biol Phys 17 (1989) 433-436
32. Chao K.S., Deasy J.O., Markman J., Haynie J., Perez C.A., Purdy J.A., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
33. Burlage F.R., Coppes R.P., Meertens H., Stokman M.A., and Vissink A. Parotid and submandibular/sublingual salivary flow during high dose radiotherapy. Radiother Oncol 61 (2001) 271-274
34. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 1987;66 Spec No:648-53.
35. Beer K.T., Zehnder D., Lussi A., and Greiner R.H. Sparing of contralateral major salivary glands has a significant effect on oral health in patients treated with radical radiotherapy of head and neck tumors. Strahlenther Onkol 178 (2002) 722-726
36. Ericson D., and Bratthall D. Simplified method to estimate salivary buffer capacity. Scand J Dent Res 97 (1989) 405-407
37. Konings A.W., Coppes R.P., and Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 62 (2005) 1187-1194
38. Blanco A.I., Chao K.S., El N.I., Franklin G.E., Zakarian K., Vicic M., et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1055-1069
39. Viswanath L., Bhanumathi G., Reddy B.K., and Prabhakaran P.S. Oral pH changes due to salivary gland irradiation during radiation therapy of oral and head and neck cancer. Indian J Dent Res 15 (2004) 137-138
40. Lacatusu S., Francu L., and Francu D. Clinical and therapeutical aspects of rampant caries in cervico-facial irradiated patients. Rev Med Chir Soc Med Nat Iasi 100 (1996) 98-202
41. Frank R.M., Herdly J., and Philippe E. Acquired dental defects and salivary gland lesions after irradiation for carcinoma. J Am Dent Assoc 70 (1965) 868-883
42. Burlage F.R., Pijpe J., Coppes R.P., et al. Variability of flow rate when collecting stimulated human parotid saliva. Eur J Oral Sci 113 (2005) 386-390